A Dose Escalation Study of Hydroxyurea in Combination With SCH900776 in Advanced Malignant Solid Tumors
NCT01521299
·
clinicaltrials.gov ↗
PHASE1
Phase
WITHDRAWN
Status
OTHER
Sponsor class
Stopped
Insufficient population of eligible patients.
Conditions
Advanced Solid Tumors
Interventions
DRUG:
Hydroxyurea
Sponsor
Dartmouth-Hitchcock Medical Center